DIN 02567725 — KISUNLA 17.5 MG
KISUNLA is a solution of Donanemab marketed by ELI LILLY CANADA INC. The full Donanemab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02567725
- Brand name
- KISUNLA
- Active ingredient
- Donanemab
- Strength
- 17.5 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- ELI LILLY CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Anti-amyloid beta monoclonal antibody
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.